New HIV treatment for people not yet on medication
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This study tests a new combination medicine for people with HIV who have never taken treatment. It aims to see if it is safe and helps reduce the amount of virus in the blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be HIV-positive and have never taken HIV medicines before.
- Your viral load (amount of virus in your blood) must be above 500 copies/mL and below a certain limit.
- If you are in an earlier phase of the study, your immune cell count (CD4) must be at least 200.
- You must not have certain other infections, like active hepatitis B or C.
- You must not have had certain cancers in the past 5 years, except for a few types like some skin cancers.
- You must not have taken the study drugs (islatravir or ulonivirine) before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral HIV medication (VH4524184) in people who have never taken HIV treatment before. It looks at how well the drug controls the virus and how safe it is.
This study tests whether giving two experimental drugs together can help your immune system find and destroy hidden HIV cells. It aims to see if this approach can reduce the amount of virus in your body even while you're on your regular HIV medications.
This trial compares a new HIV medication (ACC017) to an existing one (dolutegravir) in adults who have HIV but have never taken HIV drugs before. The goal is to see if the new pill works as well and is safe.
This study tests a new combination of two drugs to see if they can reduce the 'hidden' HIV that stays in your body even when you're on regular HIV treatment. The goal is to work toward a cure, not just control.
This study tests whether a combination of two lab-made antibodies plus an immunotherapy drug can help control HIV without daily antiretroviral pills. If successful, it might allow a safe break from your current HIV medications while keeping the virus under control.
This study tests a new shot (called VH4011499) that may help control HIV. It is given together with another shot, cabotegravir, so you might not need to take daily pills. The study is for people who have never treated their HIV before.
Hear when a new Human Immunodeficiency Virus Type 1 (HIV-1) Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.